Characteristics | Patients without VF | Patients with VF | p valuea |
---|---|---|---|
(n = 344) | (n = 46) | ||
Age, yrb | 47.3 ± 11.6 | 52.2 ± 13.1 | <0.01 |
Symptom duration, yrc | 14.1 ± 10.4 | 18.5 ± 12.4 | <0.01 |
Disease duration, yrd | 10.5 ± 9.6 | 12.5 ± 12.1 | ns |
ESR, mm/h | 9.2 ± 10.7 | 8.0 ± 8.1 | ns |
CRP, mg/L | 4.0 ± 6.5 | 2.9 ± 3.8 | ns |
BASDAI | 4.3 ± 2.3 | 4.7 ± 2.2 | ns |
BASFI | 5.0 ± 8.5 | 4.9 ± 2.9 | ns |
ASDAS-ESR | 2.2 ± 1.0 | 2.4 ± 0.9 | ns |
ASDAS-CRP | 2.2 ± 1.0 | 2.3 ± 1.0 | ns |
OWD | 1.3 ± 4.2 | 2.5 ± 5.5 | 0.09 |
mSASSS | |||
 Cervical spine | 3.4 ± 8.5 | 5.8 ± 13.2 | 0.10 |
 Thoracic spine | 9.8 ± 19.6 | 16.2 ± 25.1 | <0.05 |
 Lumbar spine | 3.6 ± 7.6 | 6.0 ± 10.3 | <0.07 |
 Cervical + lumbar spine | 7.0 ± 15.0 | 11.7 ± 21.6 | 0.06 |
 Total spine | 16.8 ± 32.8 | 27.9 ± 43.5 | <0.05 |
T-score | |||
 Lumbar spine | 0.25 ± 1.70 | 0.13 ± 1.50 | ns |
 Femoral neck | −0.70 ± 1.06 | −1.00 ± 0.97 | <0.05 |
 Total hip | −0.34 ± 1.09 | −0.59 ± 1.04 | ns |